The LMC Buying Group has concluded negotiations with flu vaccine companies for the 2018/19 season and has announced its preferred supplier for trivalent vaccines is Pfizer and for quadrivalent vaccines is Mylan.
The group’s other suppliers are Seqirus and MASTA.
A statement on the Buying Group’s website states: “We know that practices choose their vaccine supplier for different reasons, but we have ranked our preferred suppliers purely on Profit Per Dose (PPD) for ease of comparison.
“Other terms such as discounts on the NHS price, sale or return, reserves, early delivery etc. have also been negotiated and of course play a significant role in your deliberations over choice of supplier along with the evidence-base for choosing the type of vaccine that you deliver to your patients.”
All the offers are available to view on the Flu Vaccines page on the group website, but you need to login to see all the information so if this is your first visit to the website you can register for login details.